119
1.4.3 Precautionary measures
Precautionary measures need to be taken for:
• patients under anticoagulation therapy and/or with active bleeding
• patients with difficult wound haemostasis
• application of the system in the immediate vicinity of blood vessels, organs,
muscles and fascias and bradytrophic tissue (tendons, ligaments or cartilage)
• irradiated vessels and tissues
• bone fragments with sharp edges
• uncooperative patients
• wound cavities and pockets with hidden areas
• patients with ischaemia and/or circulatory disorders; the attending doctor must check whether
Suprasorb
®
CNP therapy is applicable or whether itmay be necessary toimplement other
therapy measures (e.g., revascularisation) first
1.4.4 Restrictions on use
• medical facilities where potential equalisation is required (e.g., cardiac surgery)
• potentially explosive atmospheres
• aircraft
• areas with electromagnetic radiation, e.g., MRI suites
1.5 Information for the user
• Use the Suprasorb
®
CNP P3 in accordance with its intended purpose.
• Use the Suprasorb
®
CNP P3 in accordance with its instructions for use.
• The Suprasorb
®
CNP P3 and its components should always undergo avisual inspection
and afunctional check prior to use.
• Do not allow unauthorised persons to open the Suprasorb
®
CNP P3 therapy unit.
• Assembly, setup, add-ons, maintenance and repairs must be performed by authorised
personnel.
• The Suprasorb
®
CNP P3 must undergo acheck in accordance with DIN EN 62353
performed by L&R or an L&R authorised service partner every 18 months (see Section 7.2).
• The healthcare professionals are trained in the use of the device by L&R or an
authorisedL&R sales partner. The training sessions are performed once with reference
totheinstructions for use – Sections 2, 3, 4, 6 and 11 for the qualified healthcare
professionals andSections 2, 3, 5, 6 and 11 for the patient – and documented in
themedical devices book.
• The Suprasorb
®
CNP P3 has aproduct service life of 3 years.